View More Recent Stories

May 9, 2025 04:40AM Mirum Pharmaceuticals (MIRM) PT Raised to $76 at Citizens JMP
May 8, 2025 05:20AM Mirum Pharamceuticals (MIRM) PT Raised to $76 at Evercore ISI
May 7, 2025 04:28PM Mirum Pharmaceuticals, Inc. (MIRM) Tops Q1 EPS by 1c ; Offers Guidance
Apr 14, 2025 08:32AM Mirum Pharmaceuticals' (MIRM) LIVMARLI in tablet form receives FDA approval
Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
Mar 27, 2025 08:33AM Mirum (MIRM) partner Takeda receives LIVMARLI approval in Japan
Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more
Feb 28, 2025 07:12AM Mirum Pharamceuticals (MIRM) PT Raised to $72 at H.C. Wainwright
Feb 26, 2025 04:40PM Mirum Pharmaceuticals, Inc. (MIRM) Misses Q4 EPS by 155c
Feb 24, 2025 08:30AM Mirum Pharmaceuticals' (MIRM) CTEXLI Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis
Feb 24, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on Mirum Pharamceuticals (MIRM)
Feb 21, 2025 11:56AM FDA approves Mirum Pharmaceuticals' (MIRM) genetic disorder drug
Jan 13, 2025 08:36AM Mirum Pharmaceuticals (MIRM) Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates
Nov 13, 2024 06:59AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)
Nov 12, 2024 12:51PM Mirum Pharamceuticals (MIRM) PT Raised to $70 at Stifel
Nov 12, 2024 08:06AM Mirum Pharmaceuticals, Inc. (MIRM) Tops Q3 EPS by 15c ; Offers Guidance
Oct 11, 2024 06:35AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharamceuticals (MIRM), 'affirm MIRM shares as one of our 2024 Top Picks'
Oct 10, 2024 08:30AM Mirum Pharmaceuticals (MIRM) Announces Volixibat Granted FDA Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis
Aug 8, 2024 02:38AM Mirum Pharamceuticals (MIRM) PT Raised to $44 at Baird
Aug 7, 2024 05:01PM Mirum Pharmaceuticals, Inc. (MIRM) Misses Q2 EPS by 5c ; Offers Guidance
Jul 26, 2024 03:06PM Mirum Pharmaceuticals, Inc. (MIRM) August 40 and 45 calls active as share price up 6.5%
Jul 26, 2024 02:51PM Mirum Pharmaceuticals (MIRM) said approached by Sobi about a takeover - source
Jul 25, 2024 08:35AM Mirum Pharmaceuticals' (MIRM) LIVMARLI Now Approved for PFIC in Patients 12 Months and Older
Jul 9, 2024 05:43AM Mirum Pharamceuticals (MIRM) PT Raised to $69 at JMP Securities
Jul 8, 2024 12:33PM Stifel Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)
Jul 1, 2024 06:38AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)
Jun 18, 2024 06:43AM Mirum Pharamceuticals (MIRM) PT Raised to $66 at H.C. Wainwright
Jun 17, 2024 03:22PM Mirum Pharamceuticals (MIRM) PT Raised to $62 at Evercore ISI
Jun 17, 2024 03:00PM Mirum Pharamceuticals (MIRM) PT Raised to $64 at Citi
Jun 17, 2024 01:37PM Mirum Pharamceuticals (MIRM) PT Raised to $57 at Morgan Stanley
Jun 17, 2024 10:28AM Stifel Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)
Jun 17, 2024 09:06AM Mirum Pharamceuticals (MIRM) PT Raised to $39 at Baird
Jun 17, 2024 08:41AM Citi Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)
Jun 17, 2024 08:04AM Mirum Pharmaceuticals' (MIRM) Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies
View More Recent Stories